Partnering Science for Impact
Dr. Nandan Padukone heads up the Office of Commercialization and Ventures (OCV), which he helped launch as a business center of Joslin Diabetes Center to create strategic relationships with industry and leverage Joslin’s world-leading expertise in diabetes-directed research and clinical care.
Dr. Padukone has 17 years in biotechnology management and entrepreneurial ventures involving diagnostics (Nuvera), therapeutics (Altus Pharma), bioinformatics (Silico Insights), and renewable energy (NREL). He helped launch Nuvera Biosciences as founding CEO in 2005, a venture focused on cancer therapy and pharmacogenomics, in collaboration with MD Anderson Cancer Center. At Nuvera, he has been responsible for venture capitalization, product validation, and business development, and forged alliances with cancer centers and diagnostic companies in US and Europe. He actively engaged with regulatory agencies, healthcare organizations, and patient advocacy groups.
Previously, Dr. Padukone was the founder and CEO of Silico Insights, a bioinformatics company launched in 2000, and had served previously as Director of Technology and Board Member at Altus Biologics, a spin-out venture of Vertex Pharmaceuticals. He also led scientific teams at the National Renewable Energy Laboratory (NREL) and led industrial partnerships in development of bioethanol and biodegradable polymers.
Dr. Padukone holds a Ph.D. in Biochem. Engg. from NC State University, an MBA from U. Denver, and a B. Tech. from IIT, Mumbai, India.
Dr. Nandan Padukone, Ph.D., MBA
Office of Commercialization & Ventures
Page last updated: March 09, 2017